DaVita HealthCare Partners Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by DaVita HealthCare Partners Inc. on April 17, 2015. The report discloses a significant capital market event: the completion of a registered public offering of senior notes.
Key Financial Metrics
The filing details a debt issuance rather than operational performance metrics. Key figures include:
- Debt Issuance: $1,500,000,000 aggregate principal amount.
- Instrument: 5.000% Senior Notes due 2025.
- Guarantees: The Notes are guaranteed by the Company's domestic restricted subsidiaries.
- Trustee: The Bank of New York Mellon Trust Company, N.A.
The filing text does not provide clear values for revenue, profit, cash flow, margins, or existing liquidity positions as this is a transactional report.
Material Changes
The primary material change is the increase in long-term debt obligations resulting from the $1.5 billion note issuance. This transaction alters the Company's capital structure and introduces new fixed interest obligations at a 5.000% rate maturing in 2025.
Outlook, Risks, and Contingencies
The filing references an Indenture dated April 17, 2015, which governs the terms of the Notes. The description of the Indenture is qualified in its entirety by reference to the complete terms attached as Exhibit 4.1. No specific management commentary on future outlook or operational risks is provided in this specific text, other than the execution of the debt agreement.
Investor Verification Checklist
- Verify the use of proceeds from the $1.5 billion offering in the accompanying Registration Statement (Form S-3 No. 333-203394).
- Review the full Indenture (Exhibit 4.1) for covenants, default provisions, and redemption rights.
- Confirm the list of subsidiary guarantors included in the Indenture.
- Assess the impact of the new 5.000% interest rate on the Company's overall cost of capital and debt service coverage.